PIP5K1α promotes myogenic differentiation via AKT activation and calcium release

Xiaofan Chen1, Jun Wan2, Bo Yu1,3

  • 1Shenzhen Key Laboratory for Translational Medicine of Dermatology, Biomedical Research Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Lianhua Road 1120, Shenzhen, 518036, Guangdong Province, China.

Abstract

Insights

Type I phosphatidylinositol 4-phosphate 5-kinase alpha (PIP5K1α) is crucial for skeletal muscle growth and regeneration. This study reveals PIP5K1α regulates myoblast differentiation by activating AKT and controlling calcium release.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Muscle Physiology

Background:

  • Skeletal muscle satellite cells drive muscle growth and repair.
  • Myogenic differentiation involves complex signaling pathways and kinases.
  • Type I phosphatidylinositol 4-phosphate 5-kinase (PIP5KI) is implicated in myogenesis, but its mechanism is unclear.

Purpose of the Study:

  • To elucidate the role and molecular mechanism of PIP5K1α in skeletal muscle myoblast differentiation.

Main Methods:

  • Quantitative PCR and Western blot to assess PIP5K1α expression and myogenic markers.
  • Immunostaining to confirm protein expression.
  • ELISA kits to measure phosphatidylinositol 4,5-bisphosphate levels.
  • AKT overexpression studies and calcium release assays (FLIPR).

Main Results:

  • PIP5K1α knockdown inhibited myoblast differentiation, while overexpression promoted it.
  • PIP5K1α is essential for AKT activation and calcium release during differentiation.
  • Phosphatidylinositol 4,5-bisphosphate levels were affected by PIP5K1α knockdown.

Conclusions:

  • PIP5K1α acts as a key regulator of myoblast differentiation.
  • The findings highlight PIP5K1α's role in AKT signaling and calcium dynamics in muscle development.

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.0K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

4.0K
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
16
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
Energy-releasing Steps of Glycolysis01:28

Energy-releasing Steps of Glycolysis

Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
147.3K